<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9446009</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">36058165</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">9446009</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pii">S2213-1582(22)00236-4</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2022.103171</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">103171</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Baseline characteristics of the included patients with good and poor outcome six months after cardiac arrest.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Baseline characteristics of the included patients with good and poor outcome six months after cardiac arrest.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Good outcome (n = 29)</th><th>Poor outcome (n = 19)</th><th>P-value</th></tr></thead><tbody><tr><td>Age (year)</td><td>56 (11)</td><td>66 (11)</td><td>&lt;0.01*</td></tr><tr><td>Male</td><td>24 (83)</td><td>13 (68)</td><td>0.24</td></tr><tr><td>OHCA</td><td>29 (1 0 0)</td><td>19 (100 %)</td><td>NA</td></tr><tr><td>Shockable first rhythm</td><td>29 (1 0 0)</td><td>14 (74)</td><td>&lt;0.01*</td></tr><tr><td>Duration of resuscitation (min)</td><td>12 [10–15]</td><td>23 [20–33]</td><td>&lt;0.01*</td></tr><tr><td>Absent pupillary light reflex ≥ 72 hr</td><td>0 (0)</td><td>4 (21)</td><td>&lt;0.01*</td></tr><tr><td>Motor score ≤ 3 at 72 hr</td><td>1 (3)</td><td>14 (74)</td><td>&lt;0.01*</td></tr><tr><td>Bilaterally absent SSEP response ≥ 72 hr</td><td>0 (0)</td><td>4 (21)</td><td>&lt;0.01*</td></tr><tr><td>Time ROSC-MRI (hour)</td><td>78 (24)</td><td>77 (27)</td><td>0.97</td></tr><tr><td>Comatose during MRI</td><td>10 (36 %)</td><td>18 (95 %)</td><td>&lt;0.01*</td></tr><tr><td>Treatment with sedatives during MRI (<italic>propofol, midazolam, dexmedetomidine</italic>)</td><td>10 (34 %)</td><td>17 (89 %)</td><td>&lt;0.01*</td></tr><tr><td>Treatment with opiates during MRI (<italic>morphine, sufentanil, remifentanil</italic>)</td><td>4 (14 %)</td><td>5 (26 %)</td><td>0.28</td></tr><tr><td>Survival till discharge from primary hospital</td><td>29 (1 0 0)</td><td>4 (21)</td><td>&lt;0.01*</td></tr><tr><td>CPC score at 6 months</td><td/><td/><td/></tr><tr><td> - 1</td><td>13 (45)</td><td/><td/></tr><tr><td> - 2</td><td>16 (55)</td><td/><td/></tr><tr><td> - 3</td><td/><td>3 (16)</td><td/></tr><tr><td> - 4</td><td/><td>0 (0)</td><td/></tr><tr><td> - 5</td><td/><td>16 (84)</td><td/></tr></tbody></table><table-wrap-foot><fn><p>Dichotomous variables are listed as n (%). Continuous variables are listed as mean (standard deviation) in case of normal distribution or median [IQR] otherwise. Group differences are calculated using t-tests, Man-Whitney U or chi-square tests. Significant differences are indicated by *. CPC: cerebral performance category; OHCA: out of hospital cardiac arrest; ROSC: return of spontaneous circulation.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline characteristics of the included patients with good and poor outcome six months after cardiac arrest.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Good outcome (n = 29)</th><th>Poor outcome (n = 19)</th><th>P-value</th></tr></thead><tbody><tr><td>Age (year)</td><td>56 (11)</td><td>66 (11)</td><td>&lt;0.01*</td></tr><tr><td>Male</td><td>24 (83)</td><td>13 (68)</td><td>0.24</td></tr><tr><td>OHCA</td><td>29 (1 0 0)</td><td>19 (100 %)</td><td>NA</td></tr><tr><td>Shockable first rhythm</td><td>29 (1 0 0)</td><td>14 (74)</td><td>&lt;0.01*</td></tr><tr><td>Duration of resuscitation (min)</td><td>12 [10–15]</td><td>23 [20–33]</td><td>&lt;0.01*</td></tr><tr><td>Absent pupillary light reflex ≥ 72 hr</td><td>0 (0)</td><td>4 (21)</td><td>&lt;0.01*</td></tr><tr><td>Motor score ≤ 3 at 72 hr</td><td>1 (3)</td><td>14 (74)</td><td>&lt;0.01*</td></tr><tr><td>Bilaterally absent SSEP response ≥ 72 hr</td><td>0 (0)</td><td>4 (21)</td><td>&lt;0.01*</td></tr><tr><td>Time ROSC-MRI (hour)</td><td>78 (24)</td><td>77 (27)</td><td>0.97</td></tr><tr><td>Comatose during MRI</td><td>10 (36 %)</td><td>18 (95 %)</td><td>&lt;0.01*</td></tr><tr><td>Treatment with sedatives during MRI (propofol, midazolam, dexmedetomidine)</td><td>10 (34 %)</td><td>17 (89 %)</td><td>&lt;0.01*</td></tr><tr><td>Treatment with opiates during MRI (morphine, sufentanil, remifentanil)</td><td>4 (14 %)</td><td>5 (26 %)</td><td>0.28</td></tr><tr><td>Survival till discharge from primary hospital</td><td>29 (1 0 0)</td><td>4 (21)</td><td>&lt;0.01*</td></tr><tr><td>CPC score at 6 months</td><td/><td/><td/></tr><tr><td> - 1</td><td>13 (45)</td><td/><td/></tr><tr><td> - 2</td><td>16 (55)</td><td/><td/></tr><tr><td> - 3</td><td/><td>3 (16)</td><td/></tr><tr><td> - 4</td><td/><td>0 (0)</td><td/></tr><tr><td> - 5</td><td/><td>16 (84)</td><td/></tr></tbody></table></div>Dichotomous variables are listed as n (%). Continuous variables are listed as mean (standard deviation) in case of normal distribution or median [IQR] otherwise. Group differences are calculated using t-tests, Man-Whitney U or chi-square tests. Significant differences are indicated by *. CPC: cerebral performance category; OHCA: out of hospital cardiac arrest; ROSC: return of spontaneous circulation.</transformed-table></extracted-table></extracted-tables-set>